Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

计划入组 195 人 · 首次发布于 2023 年 1 月 12 日

Orotracheal Intubation with the ORION Videolaryngoscope Versus the King Vision Videolaryngoscope in Adult Patients: ORION Trial

计划入组 50 人 · 首次发布于 2024 年 10 月 2 日

Recurrent/Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy and Safety of Nivolumab

计划入组 14 人 · 首次发布于 2025 年 8 月 3 日

GIPR(Orion)

Ghrelin targeting therapeutic (Orion Biotechnology)

Heart failure therapeutics(Orion Oyj)

Orion Corporation, Orion Pharma

Finland

Orion Corporation

Finland

ORION PHARMA

France

Orion Secures Exclusive License for Abzena's Cancer-Targeting Monoclonal Antibody

Orion Corporation Appoints Berkeley Vincent as Executive Vice President of Innovative Medicines

X-Chem and Orion Pharma Expand Collaboration to Accelerate Small Molecule Drug Discovery